Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow.

Already subscribed? Sign in now

Learn more about CME

Human Papillomavirus DNA Testing

MoreVert
AddCircleOutlineFollow
ShareShare
AddCircleOutlineFollow
Follow
ShareShare
Share
19 Apr 2019

hrHPV testing may detect more cervical intraepithelial neoplasia lesions than liquid-based cytology (BMJ 2019 Feb 6)

19 Apr 2019

hrHPV testing may detect more cervical intraepithelial neoplasia lesions than liquid-based cytology (BMJ 2019 Feb 6)

19 Apr 2019

hrHPV testing may detect more cervical intraepithelial neoplasia lesions than liquid- based cytology (BMJ 2019 Feb 6)

19 Apr 2019

cervical cancer screening with high-risk HPV (hrHPV) testing may reduce incidence of CIN 3 or worse lesions at 3 years compared to screening with liquid-based cytology (BMJ 2019 Feb 6)

17 Apr 2019

HPV testing by self-collected and clinician-collected samples may have similar sensitivity and specificity for detection of CIN 2 or worse within a national screening population (Lancet Oncol 2019 Feb)

23 Aug 2018

cervical cancer screening with primary HPV DNA testing reduces risk of CIN 3 or worse lesions compared to screening with liquid-based cytology (JAMA 2018 Jul 3)

AssignmentLatePRACTICE-CHANGING UPDATE

22 Nov 2016

co-testing with HPV DNA and cervical cytology may decrease risk of cervical cancer and CIN3+ lesions compared to cytology alone at 9- and 14-year follow-ups (BMJ 2016 Oct 4)

AssignmentLatePRACTICE-CHANGING UPDATE

13 Oct 2014

urine sampling appears useful for detection of cervical HPV (BMJ 2014 Sep 16)

CheckCircle

top